Who We Support

Recipients of funds from the Foundation include:

Massachusetts General Hospital Cancer Center
The Foundation supports the research of the Bardeesey Laboratory at the MGH Cancer Center, focusing on understanding the genetic program for pancreatic cancer initiation and progression using mouse models that resemble the human disease. The Foundation also supports the research of David T. Ting, MD at MGH that designed the microfluidic CTC-capture device named the CTC herringbone chip with the goal of understanding how circulating tumor cells (CTCs) get into blood to provide us a better understanding of the ability of cancers cells to spread and open new avenues to develop new therapies to stop this process. In addition, If CTCs can be detected early in pancreatic cancer development, the CTC herringbone chip may provide the first blood based early detection test for pancreatic cancer.

UMass Memorial Foundation Pancreatic Cancer Research Fund
The Foundation’s gift to the Pancreatic Cancer Research Fund supports the work of researchers such as Dr. Brian Lewis, who is focused on identifying correlations between specific genetic changes, tumor behavior and signal pathways in cancer.

The Foundation also supports Jennifer LaFemina, MD at UMass. Dr. LaFemina is involved in a number of active clinical and translational studies, including creation of a High Risk Pancreas Clinic in which patients who are at an increased risk of pancreatic cancer are assessed in a multidisciplinary manner and development of a pilot study evaluating the role of anti- inflammatories in the prevention (“chemoprevention”) of pancreatic cancer.

Pancreatic Cancer Action Network (a.k.a. PanCAN)
THE PANCREATIC CANCER ACTION NETWORK is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those afflicted by pancreatic cancer. PanCAN raises money for direct private funding of research—and advocate for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment. 100% of every dollar we send to PanCan funds research grants.

Lustgarten Foundation for Pancreatic Cancer Research
The mission of The Lustgarten Foundation for Pancreatic Cancer Research is to advance the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer by: increasing funding and support of research
into the biological mechanisms and clinical strategies related to prevention, diagnosis, and treatment; facilitating and enhancing the dialog among members of the medical and scientific communities; advocating an increase in the annual budget of the National Cancer Institute with emphasis on research related to pancreatic cancer; and heightening the public’s awareness of pancreatic cancer diagnosis, treatment, and prevention and providing informational support for pancreatic cancer patients, their families, and friends. According to the Foundation, Cablevision’s support of the Lustgarten Foundation ensures that 100% of every donation goes directly to pancreatic cancer research.

Johns Hopkins University, Pancreatic Cancer Early Detection Lab
This research laboratory was created to help fight pancreatic cancer. The number one goal of this laboratory is to develop a screening test for early pancreatic cancer.

The Foundation is a tax-exempt organization pursuant to Section 501(c)(3) of the Internal Revenue Code, and contributions are deductible to the extent provided by law.